The growing interest in successful weight management has led to considerable exploration into groundbreaking treatments. Lately , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activator , has shown positive results in